The prognostic power of [ 11 C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification.
Gaia NinattiCristiano PiniBeatrice Claudia BonoFabrizia GelardiLidija AntunovicBethania FernadesMartina SolliniClaudio LandoniArturo ChitiFederico PessinaPublished in: Journal of neuro-oncology (2023)
MET PET is useful for the prognostic stratification of patients with IDH-wt glial neoplasms with histological LGGs features. Considering their huge biological heterogeneity, the combination of MET PET and molecular analyses may help to improve the prognostic accuracy in these diffuse gliomas subset and influence therapeutic choices accordingly.